WORLD-CLASS SPEAKER FACULTY

Alexandre Reuben

Assistant Professor

The University of Texas MD Anderson Cancer Center

Andrew Allen

Chief Executive Officer

Gritstone Oncology

Marc Mansour

Chief Scientific Officer

Vaximm

Russell Pachynski

Assistant Professor, Division of Oncology

Washington University School of Medicine

Slavoljub Milosevic

Vice President- Technology

Medigene AG

Wouter Scheper

Senior postdoc, Haanen lab

Netherlands Cancer Institute

Philip Arlen

President & Chief Executive Officer

Precision Biologics

Enikő Tőke

Chief Scientific Officer

Treos Bio

Hideho Okada

Professor

University of California San Francisco

Stanley Leong

Professor Emeritus of Surgery

University of California, San Francisco School

Michal Bassani-Sternberg

Group leader, Ludwig Institute for Cancer Research

University Hospital of Lausanne and the University of Lausanne

Eli Gilboa

Professor of Microbiology & Immunology

University of Miami

Sijme Zeilemaker

Chief Operating Officer

Immunicum

Lei Zheng

Professor

John Hopkins School of Medicine

TJ Langer

Chief Executive Officer & President

Myst Therapeutics

Marit van Buuren

Director, T-cell Immunology

BioNTech

Nicolas Poirier

Chief Scientific Officer

OSE Immunotherapeutics

Eric Halioua

President & Chief Executive Officer

PDC*line Pharma

Jessica Fletchner

Chief Scientific Officer

Genocea

Pranay Khare

Director, Cell Therapy Development & Manufacturing

Genocea

Raymond Miller

Senior Global Product Manager, Therapeutic Materials

GenScript Biotech Corporation

Thomas Davis

Chief Medical Officer

Genocea Biosciences

Peter Joyce

Chief Executive Officer, Co-Founder

Grey Wolf Therapeutics

Gerben Zondag

Chief Executive Officer

Immunetune

Anne De Groot

Chief Executive Officer & Chief Scientific Officer

EpiVax Therapeutics

Guilhem Richard

Lead Computational Immunologist

EpiVax Therapeutics

Kevin Pojasek

Chief Executive Officer

Enara Bio

Jens Kringelum

Director, Genomic Immuno-Oncology

Exaxion Biotech

Scott Burkholz

Bioinformatics Scientist

Flow Pharma

Jennie Lill

Senior Director of Proteomics & NGS

Genentech

Ingunn Stromnes

Assistant Professor

University of Minnesota

Edward Samuel

SVP Manufacturing

Achilles Therapeutics

Stephen Albert Johnston

CEO

Calviri, Inc

Tamara Ouspenskaia

Postdoctoral Fellow

Broad Institute

Julie Rumble

Manager, Immunology Contract Services

Cayman Chemical

David Reardon

Clinical Director, Center for NeuroOncology

Dana-Farber Cancer Institute

Sivan Elloul

Director- Oncology

Rubius Therapeutics

Niranjan Sardesai

Chief Executive Officer

Geneos Therapeutics

Marc Wolfgang

Vice President of Technical Operations

Neon Therapeutics

Agnete Fredriksen

Chief Scientific Officer

Vaccibody

Heinz Lubenau

Chief Operating Officer

Vaximm

Eric Quemeneur

Executive Vice President & Chief Scientific Officer

Transgene

Lelia Delamarre

Senior Scientist, Cancer Immunology Research

Genentech

Trevor Clancy

Chief Scientific Officer & Co-Founder

OncoImmunity

Trishul Shah

Director of Business Development

PolyPeptide Group

Sean Boyle

Senior Director, Bioinformatics Applications

Personalis Inc